Annual Operating Expenses
$22.28 M
+$1.55 M+7.47%
01 December 2023
Summary:
COSCIENS Biopharma annual total operating expenses is currently $22.28 million, with the most recent change of +$1.55 million (+7.47%) on 01 December 2023. During the last 3 years, it has risen by +$14.88 million (+201.18%).CSCI Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$5.79 M
+$1.22 M+26.61%
01 September 2024
Summary:
COSCIENS Biopharma quarterly total operating expenses is currently $5.79 million, with the most recent change of +$1.22 million (+26.61%) on 01 September 2024. Over the past year, it has increased by +$3.88 million (+202.24%).CSCI Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.5% | +202.2% |
| 3 y3 years | +201.2% | +239.7% |
| 5 y5 years | +49.2% | +622.3% |
CSCI Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -72.7% | at high |
COSCIENS Biopharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.79 M(+26.6%) |
| June 2024 | - | $4.57 M(+68.5%) |
| Mar 2024 | - | $2.71 M(+17.3%) |
| Dec 2023 | $22.28 M(+7.5%) | $2.31 M(+20.8%) |
| Sept 2023 | - | $1.92 M(+0.3%) |
| June 2023 | - | $1.91 M(+22.9%) |
| Mar 2023 | - | $1.55 M(+31.3%) |
| Dec 2022 | $20.74 M(+49.8%) | $1.18 M(+36.1%) |
| Sept 2022 | - | $869.80 K(-30.9%) |
| June 2022 | - | $1.26 M(+39.2%) |
| Mar 2022 | - | $904.80 K(-30.1%) |
| Dec 2021 | $13.84 M(+87.1%) | $1.29 M(-24.1%) |
| Sept 2021 | - | $1.71 M(+17.5%) |
| June 2021 | - | $1.45 M(+18.8%) |
| Mar 2021 | - | $1.22 M(+4.0%) |
| Dec 2020 | $7.40 M(-23.5%) | $1.17 M(+22.6%) |
| Sept 2020 | - | $958.20 K(+3.3%) |
| June 2020 | - | $927.90 K(-7.1%) |
| Mar 2020 | - | $998.30 K(-2.9%) |
| Dec 2019 | $9.67 M(-35.3%) | $1.03 M(+28.2%) |
| Sept 2019 | - | $801.70 K(-41.1%) |
| June 2019 | - | $1.36 M(+10.7%) |
| Mar 2019 | - | $1.23 M(+25.7%) |
| Dec 2018 | $14.94 M(-37.8%) | $977.60 K(+16.9%) |
| Sept 2018 | - | $836.20 K(-24.5%) |
| June 2018 | - | $1.11 M(+29.7%) |
| Mar 2018 | - | $853.80 K(-65.7%) |
| Dec 2017 | $24.00 M(-21.0%) | $2.49 M(+202.1%) |
| Sept 2017 | - | $824.10 K(+8.0%) |
| June 2017 | - | $763.20 K(-29.3%) |
| Mar 2017 | - | $1.08 M(+47.9%) |
| Dec 2016 | $30.39 M(-14.2%) | $729.70 K(+20.9%) |
| Sept 2016 | - | $603.50 K(+30.1%) |
| June 2016 | - | $464.00 K(-37.5%) |
| Mar 2016 | - | $742.30 K(+64.8%) |
| Dec 2015 | $35.43 M(-5.3%) | $450.50 K(-8.9%) |
| Sept 2015 | - | $494.60 K(-29.4%) |
| June 2015 | - | $700.50 K(-2.5%) |
| Mar 2015 | - | $718.60 K(+61.8%) |
| Dec 2014 | $37.41 M(+11.3%) | $444.10 K(-26.7%) |
| Sept 2014 | - | $606.10 K(-1.5%) |
| June 2014 | - | $615.60 K(+5.0%) |
| Mar 2014 | - | $586.20 K(+12.2%) |
| Dec 2013 | $33.60 M(+7.7%) | $522.40 K(-10.4%) |
| Sept 2013 | - | $582.80 K(-13.6%) |
| June 2013 | - | $674.60 K(+15.1%) |
| Mar 2013 | - | $586.30 K(-7.2%) |
| Dec 2012 | $31.20 M(-13.8%) | $631.60 K(-18.3%) |
| Sept 2012 | - | $773.00 K(-3.1%) |
| June 2012 | - | $798.10 K(+27.2%) |
| Mar 2012 | - | $627.20 K(-5.6%) |
| Dec 2011 | $36.20 M(+7.1%) | $664.30 K(+0.7%) |
| Sept 2011 | - | $659.40 K(+1.8%) |
| June 2011 | - | $647.60 K(+20.6%) |
| Mar 2011 | - | $536.90 K(-16.3%) |
| Dec 2010 | $33.81 M | $641.30 K(+10.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $578.30 K(+28.3%) |
| June 2010 | - | $450.90 K(+0.8%) |
| Mar 2010 | - | $447.30 K(+5.3%) |
| Dec 2009 | $70.69 M(-13.3%) | $424.90 K(+25.4%) |
| Sept 2009 | - | $338.90 K(-25.7%) |
| June 2009 | - | $456.40 K(-3.7%) |
| Mar 2009 | - | $474.00 K(-1402.2%) |
| Dec 2008 | $81.58 M(+27.7%) | -$36.40 K(-105.7%) |
| Sept 2008 | - | $633.50 K(-22.1%) |
| June 2008 | - | $812.80 K(+15.4%) |
| Mar 2008 | - | $704.20 K(+25.6%) |
| Dec 2007 | $63.89 M(+18.9%) | $560.60 K(+0.2%) |
| Sept 2007 | - | $559.60 K(-2.2%) |
| June 2007 | - | $571.90 K(+45.6%) |
| Mar 2007 | - | $392.70 K(+4.3%) |
| Dec 2006 | $53.75 M(+11.5%) | $376.40 K(-3.1%) |
| Sept 2006 | - | $388.30 K(-13.3%) |
| June 2006 | - | $447.70 K(+17.8%) |
| Mar 2006 | - | $380.10 K(+154.2%) |
| Dec 2005 | $48.19 M(+15.1%) | $149.50 K(-60.8%) |
| Sept 2005 | - | $381.20 K(-17.5%) |
| June 2005 | - | $462.30 K(+65.8%) |
| Mar 2005 | - | $278.90 K(-8.6%) |
| Dec 2004 | $41.86 M(-28.5%) | $305.30 K(-6.0%) |
| Sept 2004 | - | $324.90 K(-6.0%) |
| June 2004 | - | $345.80 K(+25.2%) |
| Mar 2004 | - | $276.30 K(-14.4%) |
| Dec 2003 | $58.53 M(+107.9%) | $322.90 K(+4.1%) |
| Sept 2003 | - | $310.20 K(+13.4%) |
| June 2003 | - | $273.50 K(+46.3%) |
| Mar 2003 | - | $187.00 K(+80.0%) |
| Dec 2002 | $28.16 M(+41.9%) | $103.90 K(-48.7%) |
| Sept 2002 | - | $202.40 K(+29.2%) |
| June 2002 | - | $156.70 K(-11.1%) |
| Mar 2002 | - | $176.20 K(-7.1%) |
| Dec 2001 | $19.84 M(+49.1%) | $189.60 K(+11.4%) |
| Sept 2001 | - | $170.20 K(-28.4%) |
| June 2001 | - | $237.80 K(+113.7%) |
| Mar 2001 | - | $111.30 K(-48.9%) |
| Dec 2000 | $13.30 M(+26.3%) | $217.90 K(-12.5%) |
| Sept 2000 | - | $248.90 K(+84.4%) |
| June 2000 | - | $135.00 K(-2.0%) |
| Mar 2000 | - | $137.70 K(-51.5%) |
| Dec 1999 | $10.53 M(+63.7%) | $283.80 K(+38.9%) |
| Sept 1999 | - | $204.30 K(+0.4%) |
| June 1999 | - | $203.50 K(+53.6%) |
| Mar 1999 | - | $132.50 K(-70.4%) |
| Dec 1998 | $6.43 M(+27.9%) | $448.20 K(+128.1%) |
| Sept 1998 | - | $196.50 K(-42.3%) |
| June 1998 | - | $340.30 K(+20.8%) |
| Mar 1998 | - | $281.80 K(-85.1%) |
| Dec 1997 | $5.03 M(+122.4%) | $1.89 M(+63.5%) |
| Sept 1997 | - | $1.16 M(-20.0%) |
| June 1997 | - | $1.45 M(+11.1%) |
| Mar 1997 | - | $1.30 M |
| Dec 1996 | $2.26 M | - |
FAQ
- What is COSCIENS Biopharma annual total operating expenses?
- What is the all time high annual operating expenses for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual operating expenses year-on-year change?
- What is COSCIENS Biopharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly operating expenses year-on-year change?
What is COSCIENS Biopharma annual total operating expenses?
The current annual operating expenses of CSCI is $22.28 M
What is the all time high annual operating expenses for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual total operating expenses is $81.58 M
What is COSCIENS Biopharma annual operating expenses year-on-year change?
Over the past year, CSCI annual total operating expenses has changed by +$1.55 M (+7.47%)
What is COSCIENS Biopharma quarterly total operating expenses?
The current quarterly operating expenses of CSCI is $5.79 M
What is the all time high quarterly operating expenses for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly total operating expenses is $5.79 M
What is COSCIENS Biopharma quarterly operating expenses year-on-year change?
Over the past year, CSCI quarterly total operating expenses has changed by +$3.88 M (+202.24%)